Dr. Zaba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Lisa Zaba M.D. Ph.D., is Clinical Associate Professor of Dermatology and Director of the South Bay Cutaneous Oncology Program. She has a special interest in managing skin complications in cancer patients while they receive treatment including skin rashes, graft versus host disease, and skin cancer. She also has a special interest in rheumatologic diseases and autoimmunity that can be caused by some forms of immune based chemotherapeutics. At the South Bay Cancer Center (CCSB) she leads the multi-disciplinary melanoma clinic. Dr. Zaba completed medical school at Cornell University, PhD in immunology at Rockefeller University, Residency and Post-Doc at Stanford University in 2013.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2010 - 2013
Weill Cornell MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.Tomoko Akaike, Manisha Thakuria, Ann W Silk, Daniel S Hippe, Song Youn Park
Journal of Clinical Oncology. 2024-09-10 - Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.Alexander S Bang, Jordan T Said, Jesse Hirner, Jasmine Rana, Silvina Pugliese
Supportive Care in Cancer. 2024-05-15 - 1 citationsPrognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patients.Song Y Park, Daniel S Hippe, Lauren Zawacki, Marika Bierma, Shailender Bhatia
Journal of the American Academy of Dermatology. 2024-05-01
Press Mentions
Do You Need a COVID-19 Vaccine Booster if You Have Psoriasis?August 30th, 2021- Merkel Cell Carcinoma. Jimmy Buffett Had It. Here’s How to Reduce Your RiskSeptember 8th, 2023
- What to Know About Merkel Cell Carcinoma, the Cause of Jimmy Buffet's DeathSeptember 10th, 2023
- Join now to see all
Grant Support
- Mechanisms of BNT162b2 Vaccine Immunogenicity in Systemic Lupus Erythematosus or SclerodermaSTANFORD UNIVERSITY2024–2029
- Mechanisms of BNT162b2 Vaccine Immunogenicity in Systemic Lupus Erythematosus or SclerodermaSTANFORD UNIVERSITY2024–2029
- Mechanisms of BNT162b2 Vaccine Immunogenicity in Systemic Lupus Erythematosus or SclerodermaSTANFORD UNIVERSITY2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
